AVA's Golden Ratio
Completing Dimensionality

A.There are two. First, the dorsum is augmented with an implant (silicone, etc.) while the tip is built exclusively with autologous cartilage (septal · auricular). Because the tip skin is thinner, using an implant there carries a higher risk of visibility or extrusion — autologous tissue is the established standard. Second, aesthetics and function are never treated separately. If a deviated septum or chronic nasal obstruction is present, functional correction is performed alongside the cosmetic procedure so that both are resolved in a single recovery.

A.A silicone implant is primarily used for the dorsum, precision-carved to match each patient's skeletal structure. For patients with very thin skin or weakened capsule tissue from revision surgery, Gore-Tex or autologous rib cartilage is considered. No implant is placed at the tip — septal cartilage is the first choice there, with auricular cartilage harvested if more volume is needed.

A.The skin over the nasal tip is thinner than over the dorsum, and blood supply is more limited. Prolonged pressure from an implant can cause the skin to thin further, making the implant visible through the skin or, in severe cases, leading to extrusion. Autologous cartilage, being the patient's own tissue, carries no rejection risk and integrates stably over time — making it the standard material for tip work.

A.Yes. Septal correction performed during cosmetic surgery simultaneously improves nasal obstruction caused by the deviation. Allergic rhinitis (mucosal allergy) is managed with medication or separate procedures, but structural obstruction can see significant improvement through septoplasty. Breathing function is assessed as part of every consultation.

A.An open approach with a small transcolumellar incision is recommended as the standard. It allows direct visualisation of the internal nasal structure, enabling precise septal work, autologous cartilage fixation at the tip, and deviated nose correction. The columellar scar becomes barely noticeable over time. A closed approach is only considered in limited cases — for example, a straightforward implant exchange.

A.The majority of swelling subsides within 1–2 weeks, and the splint and taping are removed around day 5–7. The dorsal contour becomes visible at roughly one month, but residual swelling at the tip gradually resolves over 3–6 months to reveal the final shape. A full assessment of results is recommended at 6 months or later.

A.The only external scar is a small W-shaped incision — no longer than approximately 5 mm — at the base of the columella. It may be slightly visible at first, but naturally fades over 3–6 months to become virtually undetectable from the front. If alar reduction is performed simultaneously, additional incisions are placed along the inner border of the alar-cheek junction.

A.Starting two weeks before surgery, please discontinue aspirin, circulation-enhancing supplements, vitamin E, and any herbal or health supplements that may affect bleeding. Smoking cessation is strongly recommended at least four weeks prior. For the first week after surgery, avoid wearing glasses, blowing your nose forcefully, or sleeping face down. Saunas and strenuous exercise may be resumed from one month post-op.